Kinetics are crucial when targeting copper ions to fight Alzheimer's disease: an illustration with azamacrocyclic ligands - Université de Bretagne Occidentale
Article Dans Une Revue Chemistry - A European Journal Année : 2018

Kinetics are crucial when targeting copper ions to fight Alzheimer's disease: an illustration with azamacrocyclic ligands

Résumé

Targeting copper ions to either remove or redistribute them is currently viewed as a possible therapeutic strategy in the context of Alzheimer's disease (AD). Thermodynamic parameters, as for instance the copper(II) affinity of the drug candidate or the copper(II) over zinc(II) selectivity, are considered in the design of the drug candidate. In contrast, kinetic ones have been overlooked despite their probable high importance. In the present article, we use a series of azamacrocyclic ligands to demonstrate that kinetic issues must be taken into account when designing copper‐targeting drug candidates in the context of AD.
Fichier principal
Vignette du fichier
Conte-Daban-2018-Chemistry.pdf (584.23 Ko) Télécharger le fichier
Conte-Daban-2018-Chemistry_SI.pdf (1.53 Mo) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-01764900 , version 1 (30-04-2018)

Identifiants

Citer

Amandine Conte-Daban, Maryline Beyler, Raphaël Tripier, Christelle Hureau. Kinetics are crucial when targeting copper ions to fight Alzheimer's disease: an illustration with azamacrocyclic ligands. Chemistry - A European Journal, 2018, 24 (33), pp.8447-8452. ⟨10.1002/chem.201801520⟩. ⟨hal-01764900⟩
329 Consultations
244 Téléchargements

Altmetric

Partager

More